Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations
@article{TCR99394, author = {Rahul Kumar and Emily Miao and Luke Roy George Pike}, title = {Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations}, journal = {Translational Cancer Research}, volume = {14}, number = {4}, year = {2025}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/99394} }